A think tank of the Italian society of colorectal surgery (SICCR) on the surgical treatment of inflammatory bowel disease using the Delphi method: Crohn’s disease

Techniques in Coloproctology

Volumn 19, Issue 10, 2015, Pages 639-651

  Pellino, G ^a   Selvaggi, F ^a   Ghezzi, G ^b   Corona, D ^b   Riegler, G ^a   Delaini, G G ^c  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c Pederzoli Hospital   (Italy)

Author keywords

Crohn s disease; Guidelines; Inflammatory bowel disease; Surgery

Indexed keywords

C REACTIVE PROTEIN; PREDNISOLONE;

ABDOMINAL ABSCESS; ABDOMINAL PENETRATING TRAUMA; ABDOMINAL RADIOGRAPHY; ANUS FISTULA; CANCER RISK; COLONOSCOPY; COLORECTAL SURGERY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CROHN DISEASE; DELPHI STUDY; DISEASE CLASSIFICATION; EVIDENCE BASED PRACTICE; GOOD CLINICAL PRACTICE; GROWTH RETARDATION; HEALTH CARE QUALITY; ILEOCOLONOSCOPY; INTESTINAL BLEEDING; INTESTINE OBSTRUCTION; ITALY; LAPAROSCOPY; MEDICAL SOCIETY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS DRAINAGE; PERIANAL ABSCESS; PERIOPERATIVE PERIOD; PERSONALIZED MEDICINE; PHYSICIAN ATTITUDE; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PROTEIN BLOOD LEVEL; REVIEW; RISK FACTOR; SEPSIS; STEROID THERAPY; STRICTUREPLASTY; SURGEON; TRANSABDOMINAL CONTRAST ENHANCED ULTRASOUND; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT RESPONSE; CLASSIFICATION; COLON; COLONIC NEOPLASMS; COMPLICATION; CONSENSUS; CONSENSUS DEVELOPMENT; GASTROINTESTINAL ENDOSCOPY; HUMAN; ILEOSTOMY; INTESTINAL FISTULA; PATHOLOGY; PROCEDURES; SIGMOIDOSCOPY; STANDARDS; STENOSIS, OCCLUSION AND OBSTRUCTION;

COLON; COLONIC NEOPLASMS; COLORECTAL SURGERY; CONSENSUS; CONSTRICTION, PATHOLOGIC; CROHN DISEASE; DELPHI TECHNIQUE; ENDOSCOPY, GASTROINTESTINAL; EVIDENCE-BASED PRACTICE; HUMANS; ILEOSTOMY; INTESTINAL FISTULA; ITALY; LAPAROSCOPY; PRACTICE GUIDELINES AS TOPIC; SIGMOIDOSCOPY;

EID: 84942759880     PISSN: 11236337     EISSN: 1128045X     Source Type: Journal    
DOI: 10.1007/s10151-015-1368-4     Document Type: Review

References (80)

1. Selvaggi F, Pellino G, Ghezzi G, Corona D, Riegler G, Delaini GG; on behalf of the Italian Society of Colo-Rectal Surgery SICCR (2015) A think tank of SICCR on the surgical treatment of Inflammatory Bowel Diseases with Delphi method: ulcerative colitis. Tech Coloproctol. doi:10.1007/s10151-015-1367-5
2. Satsangi J, Silverberg MS, Vermeire S, Colombel JF (2006) The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 55:749–753
3. Cosnes J, Cattan S, Blain A et al (2002) Long-term evolution of disease behavior of Crohn’s disease. Inflamm Bowel Dis 8:244–250
4. Pellino G, Sciaudone G, Selvaggi F, Riegler G (2015) Delayed diagnosis is influenced by the clinical pattern of Crohn’s disease and affects treatment outcomes and quality of life in the long term: a cross-sectional study of 361 patients in Southern Italy. Eur J Gastroenterol Hepatol 27:175–181
5. Hovde Ø, Moum BA (2012) Epidemiology and clinical course of Crohn’s disease: results from observational studies. World J Gastroenterol 18:1723–1731
6. Peyrin-Biroulet L, Harmsen WS, Tremaine WJ, Zinsmeister AR, Sandborn WJ, Loftus EV Jr (2012) Surgery in a population-based cohort of Crohn’s disease from Olmsted County, Minnesota (1970–2004). Am J Gastroenterol 107:1693–1701
7. Dignass A, Van Assche G, Lindsay JO, European Crohn’s and Colitis Organisation (ECCO) et al (2010) The second European evidence-based consensus on the diagnosis and management of Crohn’s disease: current management. J Crohns Colitis 4:28–62
8. Hindryckx P, Baert F, Hart A, Armuzzi A, Panès J, Peyrin-Biroulet L, Clinical Trial Committee Clincom of the European Crohn’s and Colitis Organisation (ECCO) (2014) Clinical trials in luminal Crohn’s disease: a historical perspective. J Crohns Colitis 8:1339–1350
9. Mendoza JL, Abreu MT (2009) Biological markers in inflammatory bowel disease: practical consideration for clinicians. Gastroenterol Clin Biol 3(33 Suppl):S158–S173
10. Panes J, Bouhnik Y, Reinisch W et al (2013) Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis 7:556–585
11. Spinelli A, Fiorino G, Bazzi P et al (2014) Preoperative magnetic resonance enterography in predicting findings and optimizing surgical approach in Crohn’s disease. J Gastrointest Surg 18:83–90
12. Rieder F, de Bruyn JR, Pham BT et al (2014) Results of the 4th scientific workshop of the ECCO (Group II): markers of intestinal fibrosis in inflammatory bowel disease. J Crohns Colitis 8:1166–1178
13. Castiglione F, Mainenti PP, De Palma GD et al (2013) Noninvasive diagnosis of small bowel Crohn’s disease: direct comparison of bowel sonography and magnetic resonance enterography. Inflamm Bowel Dis 19:991–998
14. Ripolles T, Rausell N, Paredes JM, Grau E, Martinez MJ, Vizuete J (2013) Effectiveness of contrast-enhanced ultrasound for characterisation of intestinal inflammation in Crohn’s disease: a comparison with surgical histopathology analysis. J Crohns Colitis 7:120–128
15. Pellino G, Sciaudone G, Candilio G, Campitiello F, Selvaggi F, Canonico S (2014) Effects of a new pocket device for negative pressure wound therapy on surgical wounds of patients affected with Crohn’s disease: a pilot trial. Surg Innov 21:204–212
16. Shatari T, Clark MA, Yamamoto T et al (2004) Long strictureplasty is as safe and effective as short strictureplasty in small-bowel Crohn’s disease. Colorectal Dis 6:438–441
17. Nguyen GC, Elnahas A, Jackson TD (2014) The impact of preoperative steroid use on short-term outcomes following surgery for inflammatory bowel disease. J Crohns Colitis 8:1661–1667
18. Ahmed Ali U, Martin ST, Rao AD, Kiran RP (2014) Impact of preoperative immunosuppressive agents on postoperative outcomes in Crohn’s disease. Dis Colon Rectum 57:663–674
19. Yang ZP, Hong L, Wu Q, Wu KC, Fan DM (2014) Preoperative infliximab use and postoperative complications in Crohn’s disease: a systematic review and meta-analysis. Int J Surg 12:224–230
20. Selvaggi F, Pellino G, Canonico S, Sciaudone G (2015) Effect of preoperative biologic drugs on complications and function after restorative proctocolectomy with primary ileal pouch formation: systematic review and meta-analysis. Inflamm Bowel Dis 21:79–92
21. Hanauer SB, Sandborn W, Practice Parameters Committee of the American College of Gastroenterology (2001) Management of Crohn’s disease in adults. Am J Gastroenterol 96:635–643
22. Bemelman WA, Ivenski M, van Hogezand RA, Hermans J, Veenendaal RA, Griffioen G (2001) How effective is extensive nonsurgical treatment of patients with clinically active Crohn’s disease of the terminal ileum in preventing surgery? Dig Surg 18:56–60
23. Berg DF, Bahadusingh AM, Kaminski DL, Longo WE (2002) Acute surgical emergencies in inflammatory bowel disease. Am J Surg 184:45–51
24. Ikeuchi H, Yamamura T (2002) Free perforation in Crohn’s disease: review of the Japanese literature. J Gastroenterol 37:1020–1027
25. Spinelli A, Allocca M, Jovani M, Danese S (2014) Review article: optimal preparation for surgery in Crohn’s disease. Aliment Pharmacol Ther 40:1009–1022
26. Werbin N, Hadad R, Greenberg R, Karin E, Skornick Y (2003) Free perforation in Crohn’s disease. Isr Med Assoc J 5:175–177
27. Maconi G, Sampietro GM, Parente F et al (2003) Contrast radiology, computed tomography and ultrasonography in detecting internal fistulas and intra-abdominal abscesses in Crohn’s disease: a prospective comparative study. Am J Gastroenterol 98:1545–1555
28. Lawrance IC, Rogler G, Bamias G et al (2014) Cellular and molecular mediators of intestinal fibrosis. J Crohns Colitis. doi:10.1016/j.crohns.2014.09.008
29. Latella G, Rogler G, Bamias G et al (2014) Results of the 4th scientific workshop of the ECCO (I): pathophysiology of intestinal fibrosis in IBD. J Crohns Colitis 8:1147–1165
30. Rieder F, Zimmermann EM, Remzi FH, Sandborn WJ (2013) Crohn’s disease complicated by strictures: a systematic review. Gut 62:1072–1084
31. Atreja A, Aggarwal A, Dwivedi S et al (2014) Safety and efficacy of endoscopic dilation for primary and anastomotic Crohn’s disease strictures. J Crohns Colitis 8:392–400
32. Veroux M, Angriman I, Ruffolo C et al (2003) Severe gastrointestinal bleeding in Crohn’s disease. Ann Ital Chir 74:213–215 (discussion 216)
33. Alós R, Hinojosa J (2008) Timing of surgery in Crohn’s disease: a key issue in the management. World J Gastroenterol 14:5532–5539
34. Newby EA, Sawczenko A, Thomas AG, Wilson D (2005) Interventions for growth failure in childhood Crohn’s disease. Cochrane Database Syst Rev 3:CD003873
35. Sebastian S, Hernández V, Myrelid P et al (2014) Colorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I). J Crohns Colitis 8:5–18
36. Egan L, D’Inca R, Jess T et al (2014) Non-colorectal intestinal tract carcinomas in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (II). J Crohns Colitis 8:19–30
37. Lovasz BD, Lakatos L, Golovics PA et al (2003) Risk of colorectal cancer in Crohn’s disease patients with colonic involvement and stenosing disease in a population-based cohort from Hungary. J Gastrointestin Liver Dis 22:265–268
38. Mitchell PJ, Salmo E, Haboubi NY (2007) Inflammatory bowel disease: the problems of dysplasia and surveillance. Tech Coloproctol 11:299–309
39. Winawer S, Fletcher R, Rex D, Gastrointestinal Consortium Panel et al (2003) Colorectal cancer screening and surveillance: clinical guidelines and rationale—update based on new evidence. Gastroenterology 124:544–560
40. Itzkowitz SH, Harpaz N (2004) Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology 126:1634–1648
41. Kavanagh DO, Carter MC, Keegan D et al (2014) Management of colorectal cancer in patients with inflammatory bowel disease. Tech Coloproctol 18:23–28
42. Parks AG, Gordon PH, Hardcastle J (1976) A classification of fistula in-ano. Br J Surg 63:1–12
43. Bell SJ, Williams AB, Wiesel P, Wilkinson K, Cohen RC, Kamm MA (2003) The clinical course of fistulating Crohn’s disease. Aliment Pharmacol Ther 17:1145–1151
44. Irvine EJ (1995) Usual therapy improves perianal Crohn’s disease as measured by a new disease activity index. McMaster IBD Study Group. J Clin Gastroenterol 20:27–32
45. Papay P, Ignjatovic A, Karmiris K et al (2013) Optimising monitoring in the management of Crohn’s disease: a physician’s perspective. J Crohns Colitis 7:653–669
46. Spinelli A, De Cassan C, Sacchi M et al (2012) Imaging modalities for perianal Crohn’s disease. Curr Drug Targets 13:1287–1293
47. Siddiqui MR, Ashrafian H, Tozer P et al (2012) A diagnostic accuracy meta-analysis of endoanal ultrasound and MRI for perianal fistula assessment. Dis Colon Rectum 55:576–585
48. Buchanan GN, Halligan S, Bartram CI, Williams AB, Tarroni D, Cohen CR (2004) Clinical examination, endosonography, and MR imaging in preoperative assessment of fistula in Ano: comparison with outcome-based reference standard. Radiology 233:674–681
49. Gecse KB, Bemelman W, Kamm MA, World Gastroenterology Organization, International Organisation for Inflammatory Bowel Diseases IOIBD, European Society of Coloproctology and Robarts Clinical Trials, World Gastroenterology Organization International Organisation for Inflammatory Bowel Diseases IOIBD European Society of Coloproctology and Robarts Clinical Trials (2014) A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn’s disease. Gut 63:1381–1392
50. Hvas CL, Dahlerup JF, Jacobsen BA et al (2011) Diagnosis and treatment of fistulising Crohn’s disease. Dan Med Bull 58:C4338
51. Sciaudone G, Di Stazio C, Limongelli P et al (2010) Treatment of complex perianal fistulas in Crohn disease: infliximab, surgery or combined approach. Can J Surg 53:299–304
52. Pellino G, Selvaggi F (2014) Surgical treatment of perianal fistulizing Crohn’s disease: from lay-open to cell-based therapy—an overview. ScientificWorldJournal 2014:146281
53. Sciaudone G, Pellino G, Riegler G, Selvaggi F (2011) Infliximab in drug-naïve patients with failed ileorectal anastomosis for Crohn’s disease: a new chance for sparing the rectum? Eur Surg Res 46:163–168
54. Yamamoto T, Allan RN, Keighley MR (2000) Effect of fecal diversion alone on perianal Crohn’s disease. World J Surg 24:1258–1262 (discussion 1262–1263)
55. Aratari A, Papi C, Leandro G, Viscido A, Capurso L, Caprilli R (2007) Early versus late surgery for ileo-caecal Crohn’s disease. Aliment Pharmacol Ther 26:1303–1312
56. Panis Y (2002) Surgical treatment for Crohn’s disease. Ann Chir 127:9–18
57. Tilney HS, Constantinides VA, Heriot AG et al (2006) Comparison of laparoscopic and open ileocecal resection for Crohn’s disease: a metaanalysis. Surg Endosc 20:1036–1044
58. Lesperance K, Martin MJ, Lehmann R, Brounts L, Steele SR (2009) National trends and outcomes for the surgical therapy of ileocolonic Crohn’s disease: a population-based analysis of laparoscopic vs. open approaches. J Gastrointest Surg 13:1251–1259
59. Polle SW, Wind J, Ubbink DT, Hommes DW, Gouma DJ, Bemelman WA (2006) Short-term outcomes after laparoscopic ileocolic resection for Crohn’s disease. A systematic review. Dig Surg 23:346–357
60. Yamamoto T, Keighley MR (1999) Proctocolectomy is associated with a higher complication rate but carries a lower recurrence rate than total colectomy and ileorectal anastomosis in Crohn colitis. Scand J Gastroenterol 34:1212–1215
61. Andersson P, Olaison G, Hallbook O, Sjodahl R (2002) Segmental resection or subtotal colectomy in Crohn’s colitis? Dis Colon Rectum 45:47–53
62. Tekkis PP, Purkayastha S, Lanitis S et al (2006) A comparison of segmental vs subtotal/total colectomy for colonic Crohn’s disease: a meta-analysis. Colorectal Dis 8:82–90
63. Lian L, Stocchi L, Shen B et al (2015) Prediction of need for surgery after endoscopic balloon dilation of ileocolic anastomotic stricture in patients with Crohn’s disease. Dis Colon Rectum 58:423–430
64. Campbell L, Ambe R, Weaver J, Marcus SM, Cagir B (2012) Comparison of conventional and nonconventional strictureplasties in Crohn’s disease: a systematic review and meta-analysis. Dis Colon Rectum 55:714–726
65. Poggioli G, Laureti S, Pierangeli F, Ugolini F (2003) A new model of strictureplasty for multiple and long stenoses in Crohn’s ileitis: side-to-side diseased to disease-free anastomosis. Dis Colon Rectum 46:127–130
66. Selvaggi F, Sciaudone G, Giuliani A, Limongelli P, Di Stazio C (2007) A new type of strictureplasty for the treatment of multiple long stenosis in Crohn’s disease. Inflamm Bowel Dis 13:641–642
67. Michelassi F, Upadhyay GA (2004) Side-to-side isoperistaltic strictureplasty in the treatment of extensive Crohn’s disease. J Surg Res 117:71–78
68. Reese GE, Purkayastha S, Tilney HS, von Roon A, Yamamoto T, Tekkis PP (2007) Strictureplasty vs resection in small bowel Crohn’s disease: an evaluation of short-term outcomes and recurrence. Colorectal Dis 9:686–894
69. Sampietro GM, Sartani A, Danelli P et al (2003) Strictureplasty in the surgical treatment of complicated Crohn’s disease. Ann Ital Chir 74:659–663
70. Scarpa M, Angriman I, Barollo M et al (2004) Role of stapled and hand-sewn anastomoses in recurrence of Crohn’s disease. Hepatogastroenterology 51:1053–1057
71. Yamamoto T (2005) Factors affecting recurrence after surgery for Crohn’s disease. World J Gastroenterol 11:3971–3979
72. Choy PY, Bissett IP, Docherty JG, Parry BR, Merrie A, Fitzgerald A (2011) Stapled versus handsewn methods for ileocolic anastomoses. Cochrane Database Syst Rev 9:CD004320
73. Maggiori L, Panis Y (2014) Laparoscopy in Crohn’s disease. Best Pract Res Clin Gastroenterol 28:183–194
74. Tavernier M, Lebreton G, Alves A (2013) Laparoscopic surgery for complex Crohn’s disease. J Visc Surg 150:389–393
75. De Cruz P, Kamm MA, Prideaux L, Allen PB, Desmond PV (2012) Postoperative recurrent luminal Crohn’s disease: a systematic review. Inflamm Bowel Dis 18:758–777
76. Reese GE, Nanidis T, Borysiewicz C, Yamamoto T, Orchard T, Tekkis PP (2008) The effect of smoking after surgery for Crohn’s disease: a meta-analysis of observational studies. Int J Colorectal Dis 23:1213–1221
77. Onali S, Petruzziello C, Calabrese E et al (2009) Frequency, pattern, and risk factors of postoperative recurrence of Crohn’s disease after resection different from ileo-colonic. J Gastrointest Surg 13:246–252
78. Shen FC, Zhang HJ, Zhao XD, Cao RS, Shi RH (2012) Purine analogues compared with mesalamine or 5-ASA for the prevention of postoperative recurrence in Crohn’s disease: a meta-analysis. Int J Clin Pract 66:758–766
79. Renna S, Cammà C, Modesto I et al (2008) Meta-analysis of the placebo rates of clinical relapse and severe endoscopic recurrence in postoperative Crohn’s disease. Gastroenterology 135:1500–1509
80. Tursi A, Elisei W, Picchio M et al (2014) Comparison of the effectiveness of infliximab and adalimumab in preventing postoperative recurrence in patients with Crohn’s disease: an open-label, pilot study. Tech Coloproctol 18:1041–1046